Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2024-07-25 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges (BSE and NSE) regarding an environmental regulatory issue — specifically, a closure notice issued by the Gujarat Pollution Control Board (GPCB) for the company's Ankleshwar facility. The document references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a regulatory event affecting the company, not a financial report, audit, or management discussion. It does not contain financial data, earnings, or detailed report content. The document length is short (2739 characters) and is an announcement of a regulatory development. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories such as Environmental & Social Information (SR) or Legal Proceedings Report (LTR). Although it relates to an environmental closure notice, it is not a detailed ESG report but a regulatory announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-07-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Glenmark Life Sciences Limited addressed to stock exchanges, informing them about an upcoming earnings call scheduled for July 26, 2024. It includes details such as date, time, dial-in numbers, and contact persons for the call. The document does not contain any financial results or substantive financial data itself; it is an announcement of the earnings call event. According to the classification rules, announcements about earnings calls or invitations to such calls are best classified as Call Transcript (CT) only if they contain the transcript. Since this document is only an invitation/announcement for the earnings call, it does not qualify as a transcript. It is not a report publication announcement (RPA) because it does not mention a report being attached or published. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event, since no other category fits better and it is not the actual earnings release (ER) or transcript (CT).
2024-07-18 English
Board Meeting — GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 25-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Compan…
Regulatory Filings
2024-07-18 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification dated July 18, 2024, addressed to stock exchanges regarding an upcoming Board Meeting scheduled for July 25, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2024. The document also mentions the closure of the trading window for insider trading compliance. The document is short (2253 characters) and serves as an announcement of a future event (board meeting and financial results approval), not the financial results report itself. It does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about the board meeting and financial results approval schedule, not the actual interim report or earnings release.
2024-07-18 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice dated July 18, 2024, informing the stock exchanges about an upcoming Board Meeting scheduled for July 25, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2024. It also mentions the closure of the trading window for insider trading compliance. The document does not contain any financial data or detailed results but is an announcement of a future event related to financial reporting. The length is only 2253 characters, which is short and typical for an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing about a board meeting and upcoming financial results approval, not the financial report itself or a detailed management discussion.
2024-07-18 English
Updates
Major Shareholding Notification Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the sale of promoter shares to meet the Minimum Public Shareholding (MPS) requirements as per SEBI regulations. It details the reduction in promoter shareholding percentage and compliance timelines. The document is an announcement of a shareholding change related to regulatory compliance, specifically about promoter shareholding levels. It does not contain financial statements, audit information, or detailed financial results. It is not a report but an intimation or notification about shareholding changes. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2024-07-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.